An evaluation of the potential of HBED as an orally effective iron-chelating drug

Seminars in Hematology

Volumn 27, Issue 2, 1990, Pages 105-111

  Grady, Robert W ^a,b   Hershko, Chaim ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERIPRONE; N,N' BIS(2 HYDROXYBENZYL)ETHYLENEDIAMINE N,N' DIACETIC ACID; PYRIDINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; BIOLOGICAL MODEL; CONFERENCE PAPER; CYTOCHEMISTRY; FECES; HISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; IRON CHELATION; LIVER; METHODOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPLEEN; THALASSEMIA MAJOR; URINE;

ADMINISTRATION, ORAL; ANIMAL; CHELATION THERAPY; CHEMISTRY; EDETIC ACID; FEMALE; IRON CHELATING AGENTS; MALE; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025267327     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)